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Objective. Thisstwly was dertgned tocmnine whether patients 
with eerenary qestic angina have en impaired corenary artery 
dilator response to substance P. p11 endathrlium~dependenl vase. 
dilator. 
Reckground, lntpsirment of the endotbelium.dependent v se. 
dilator response has been sugbested tobe invalved in the patho. 
genesis Of WrenPry spasm. 
Methods. In 11 patients with ewenary spastic angina and II 
mntral patients, wbrbmce P was infused into the coronary artery 
at 20 pmellmin far 5 min. focrementat de= of acatykbeline were 
tbeo iojected inte the rorensry artery. The &fee@ of those drugs 
and nitregtyeerin on the corenary artery diameter were qesntite. 
timely analyzed. 
k!csufIs. Rem’t rate, &dir bled pressure and ratapressere 
~reduet did net chaos afkr wbatance P btbsios. in I1 tnrenarv 
kies of the paliP& with ewenary SQsSttC angina, spasm wei 
induced with acst~kholine, At the site of careo~:y s~esm dew- 
mated, tbe lumen diameter, which was 1.6 + 0.5 IRK at baseline, 
increased to 2.1 k 0.7 mm after substance P infusion (Q < 0.01). 
Coronary spasm not only is the cause of variant angina (l-3) 
be? also plays an important role in the pathogenesis of the 
otter f&s of acute ischemic syndrome, in&ding unstable 
angina and acute myocardial infarction (4-6). Althowh lh? 
p&se mechanism of coronary spasm is still to be~eluci- 
dated, it has been suggested that spasm may be precipitated 
by endothelial injury due to atherosclerosis. Previous exper- 
imental (8,9) and clinical studies (10-13) have shown that the 
atherosclerotic process damages endothelium-dependenI 
vasodilation and that stimulation with acetykholine is abol- 
ished by means of the muscarinic receptor. We have shown 
(14.15) that intracoronary injection of acetylcholine induces 
coronary spasm in XQ% of patients with variant ancina. We 
also have shown (16) that stimulation of the comna;y artery 
It decrassed te0.2 C 0.3 rem during aeetylchaline-induePd spwm 
tp < O.Gitl) and increased to 2.3 I 0.8 mot after nitmglywbt 
administration (Q < 0.001 vs. basellnc aed p = NS VS. atler 
substance P iefwiusion). Of the 12 arteries wtth spesm, 5 were 
aneiwraebicallv normsl and the ether 7 were mtnlmallv er 
mode&&ty sthdorleretie: the diameter ebaap a%r sehstak P 
was +2g t 20% and t30 2 22%. rrs~ectivelv o = NSI. In 
eentrel patients, the diameter of the miidlo p&&n tithe left 
anterior darendiog artery, which was 2.0 * 0.4 mm at basetino, 
increased to 2.5 r 0.4 mm atIer substaeee P b,fesion tp < O.oOlt. 
,patients. 
Concfwions. Substnnce P dilated Le artery with spasm of tbe 
pattints with coronary spastic angina to P degree similar to that in 
centret patients, indi&g the prffcrved endethrtium~depeedmt 
dilator rerpenr at he site of ewenary spasm by way of substaeer 
P recrpter. 
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H, receptor with borecoronary histamine infusion causes 
vasodilation even at the site of spasm. presumably through 
release of the endotheliom-derived relaxing factor, in more 
than two thirds of patients with variant angina and aogio- 
graphically normal coronary arteries or minimal atheroscle- 
rotic lesions. Thus, it is still tmclear whether the endotheli- 
urn-dependent vasodilator esponse of the artery with spasm 
is impaired. Conversely, nitroglycerin, an endothelium- 
independent vasedilator. has been shown to dilate the arterv 
with spasm of patients with variant angina (17). 
Substance P. a vasoactive neuroceptide consistinn of II 
amino acids (18,19), causes vasodilkdn through the klease 
of endothelium-derived relaxing factor from the vascular 
endothelium (20). A recent clinical study has shown the! 
intracoronary infusion of substance P dilates the human 
coronary artery without a&cling systemic hemodynamics 
(21). In the present study. intracoronary infusion of aub- 
stance P was performed in padems with coronary spastic 
angina, and its effect on lumen diameter was quantitatively 
analyzed. especially at the site of coronary spasm. The 
results were then compared with those obtained from control 
patients with aegiographically normal or nearly normal car- 
onary aneriograms and without coronary spasm. 
Methods 
Study patients (Table 1). The study group comprised I I 
patients (9 men and 2 women with a mean age of 65 years 
[range 54 to 721) with coronary spastic angina in whom 
coronary spasm-was dofume& &ring ai angiographic 
study. Eiaht of the II &ems showed ST sezzment elevation 
on &her~nterinr or i&rim leads of the el&ocardiogram 
(ECG) during a spontaneous anginal attack occurring at rest 
and thus were diagnosed as having variant angina. The other 
three patients showed ST segment depression on the ECG 
during an angina1 attack occurring spontaneously at rest (one 
patient) or induced by hyperventilation and by iniracoronary 
injection of acetykholine (two patients). These three pa- 
tients had episodes of angina at rest occurring from midnight 
to early morting, as seen in patients with variant angina. 
This study also included II control patients (3 men and 8 
women) with angiogmphically normal or nearly normal 
corcmmy arteries. Their mean age was 56 years (range 43 IO 
68). which was significantly lower than that of the patients 
with coronary spastic angina (p < 0.01, unpaired r test). 
These control patients underwent diagnostic cardiac cathe- 
terization because of ad atypical chest pain syndrome. 
Treadmill exercise testing and a hyperventilation test were 
performed before cardiac catheterization i  all patients, and 
n&her an&d nor ischemic ST regment changes on the 
ECG were induced in any of the patients. Intracoronarj’ 
irtjection of acetylcholine into the left and right coronary 
arteries, which was performed after the infusion of sub- 
stance P and before administration of nitroglycerin, did not 
induce coronary spasm in any patient. 
Both in the patients with coronary spastic angina and in 
the control group, all medications except sublingual nitm- 
glycerin were withdrawn at least 3 days before the study. No 
study padem had taken nitroglycerin within 6 h of the study. 
No patient had previous myocardial iniaccrion, congesove 
heart failure. allergy, active peptic ulcer, chronic obrtmctive 
lung disease or other serious disease. Wrkten, informed 
consem was obtained fmm all patients before the c’udy. The 
study protocol was in agreement with the guideline, ap- 
proved by the ethics committee at our institution. 
Cardiac catheterization and ang@xpFde study. Coro- 
nary artetiogmphic study was performed with the Sones 
technique by using a USC1 Sones angingmphic catheter in 
the morning while the patient was fasting. A bipolar elec- 
trode catheter (USCl) was inserted into the right ventricular 
apex through the right femoral vein and was connected to a 
temporary pacemaker set at a rate of 40 to SO beatslmin. 
Corcnxy ticdogram~ were taken in the right anterior 
oblique projection for the leii coronary artery and in the left 
anterior oblique pmjection for the tight coronary artery 
during the baseline and study periods. Finally, arteriograms 
were taken in multiple projections after administration of 
sublingual nitroglycerin, and the severity of the basic core- 
nary artery lesion was determined. The relations among 
focal spt, patient and height of the image tube were kept 
constant during the angiogmphic study. Three ECG leads (I, 
aVF and V,) and arterial pressure were continuously moni- 
tored on an oscilloscope during the study. Twelve ECG 
leads were recorded at appropriate intervals. 
Study prutoml. Substance P (Sigma) was diluted in :or- 
mal saline solution to stock solutions for storage at a 
concentration of I x 1Gm6 M, and the solutions were frozen 
at -20°C. Immediately before the angiogmphic study, the 
frozen substance P solution was dissolved and further di- 
luted in normal saline solution for a final concentration of 
10 pmotlml. After baseline angiography of the left and right 
coronary arteries, intracoronary administration ofsubstance 
P and rcrlylcholine was performed according to the follow- 
ing protoc& 
I, The substance P s&nion was infused into the lefl coro- 
nary artery at a rate of 2 mlimin (that IS, 20 pmollminl 
for 5 &and the left :oronary artery was filmed. The 
dose of substance P was determined on the basis of our 
preliminary study and the previous study by the other 
investigators. Thus. in our preliminary study. intracor- 
onary infusion of subsrance P at 2 pmollmin for 5 min 
rhwcd no significant effect on the lumen dlamererofthe 
coronary artery; it was previously reported (21) thal 
ictracoronary infusion of substance Pat ~44.8 pmoilmm 
showed systemic effects, such as a reduction of arterial 
blood pressure. 
2. Five minutes after cessation of the infusion of substance 
P, incremental doses of acetylcholinc (20.50 and 100 Fg) 
wcrc injected into the left coronary artery until coronary 
spasm was induced or the maximal dose (LOO @ was 
reached. The detaiir of the method of injecling acetyl- 
choline were repor!ed previously (14.15). Each dose of 
acetyicholine was injected for a 20-s period. Coronary 
angiography was performed 1 mitt after cessation of the 
injection of each dose cf acctylchohne. The time interval 
between injection of each dose of acetylcholins was 
5 min. 
3. The substance P solution was then iniiised at the same 
rate into the right coronary artery for 5 min, and the richt 
coronary artery was filmed. This procedure was per- 
formed only in the patient in whom spasm of the right 
coronary artery was predicted to occur. 
4. Incremental doses of acctylcholinc (20 and SO pg) welt: 
finally injected into the right coronary artery until spasm 
was induced or the maximal dose (50 p&) was reached. 
Coronary spasm was defined as total or subtotal occh- 
sion or severe vasoconstriction of the coronary artery asso- 
ciated with signs of myocardial ischemia, such as chest pain 
and ischemic ST segment changes. When coronary spasm 
was induced by acetylcholine and induced spasm did not 
resolve spontaneously within 5 min. or angina1 chest pain 
persisted for r2 min or hemodynamic instability due to 
ischemia developed. 100 to 2W fig of nitroglycerin was 
injected into the coronary artery involved. 
Quantitative coronary angiography. Measurement of the 
lumen diameter of the coronary artery was performed quan- 
titatively with the use of a computer-assisted coronary 
angiography analysis system. End-diastolic tine films most 
clearly visualizing the stenotic lesion were videodigitized 
and stored in the cardiac image analysis systen: (Cardio 500, 
Kontron lnstrumentsl. Automated contour detection was 
performed by a geometric edge differentiation technique 
similar to the method described by Rciber et al. (23). Details 
of the method were described in our previous study (24) in 
which the technique was validated. 
Tke measurernerd was performed by two investigators. If 
the investigators did not agree on a segment of the detected 
contours, especially in the stenotic lesion. they discussed the 
proper positions and corrected them inleractively with the 
cursor. Analysis of intraobserver and interobserver variab.bil- 
ily for mcasurcment of coronary artery diameter showed 
high reproducibility (I = 0.99. SEE = 0.05 mm, p < O.Wl: 
and r = 0.99, SEE = 0.04 mm, p < 0.001. respectively). 
In the patients with coronary spastic angina, lumen 
diameter was measured at the site of induced coronary 
spasm (that is, at the site with the greatest reduciion in 
diameter during the induced spasm); measurements were 
performed for the am&grams at baseline, after administra- 
tion of substance P, during coronary spasm induced 
by acetylcholine and after administration of nitroglycerin. 
Lumen diameter was also measured at the midportion of 
the artery without spasm. lo the IO patients with spasm 
of the left anterior descending or the right coronary artery, 
the diameter at the midportion of the circumflex artery was 
measured; in the single patient with spasm of the I& 
circumflex artery, the diameter at the midportion of the left 
anterior descending artery was measured. In control pa- 
tients. the diameter was measured at the midportion of the 
left anterior descending artery before and after administra- 
tion of substance P, acctylcholine and nitroglycerin. 
Statistical analysis. All data are shown as the mean value 
r I SD. The effects of substance P, acetylcholine and 
nitroglycerin on lumen diameter were statistically analyzed 
with an analysis of variance (ANOVA) for repeated mea- 
sures; if a significant change was detected by ANOVA, the 
Fisher protected least significant difference multiple compar- 
ison test was performed to assess which individual differ- 
ewes were statistically significant. Percent changes in lumen 
diameter after administration of substance P and nitroalyc- 
erin were compared with use of ANOVA among the art&es 
with and without spasm in the patients with coronary spastic 
angina and the left anterior descending artery of control 
patients. ‘The arteries with spasm were classified into two 
gronp~ according to the presence or absence of fixed stenotic 
lesion and the percent change in diameter after infusion of 
substance P was compared with co unpaired t test. The c&x 
of substance P on systemic hemodynamic variables was 
analyzed with a paired t test. A p value < 0.05 was 
considered statistically significant. 
Eficeis of subrtsnee P on systernlc hemodynsrnie variables 
(Table 2). Intracoronxy infusion of substance P showed no 
atmreciahle effects on heart rate. svstolic blood pressure and 
rate-pressure product either in tie patients with coronary 
spastic angina or in the control patients. Thus, the effect of 
substance P on the coronary artery diameter in the present 
study was most likely a direct effect of the drug and not a 
result of its systemic effect or an effect on myocardial 
oxygen consumption. 
Etkets of substance P, acetykholine and nitroglycerin in 
patients with euronary spastic angina. Effects on rhe rporm 
de dimmer. In the II patients with coronary spastic 
angina, coronary spasm was documented after acetylcholine 
injection in 12 arteries. including 6 left anterior descending 
arteries, I left circomflex aflery and 5 right coronary arteries 
(Table I). Total occiuston was induced in eight artenes and 
suhtotel occlusio” or severe diffuse constnct~on I” the rc- 
maining four. The lumen diameter of the spasm site was 1.6 
f 0.5 mm 31 baseline and increased 1” 2. I + 0.7 mm in all 
patients after substance P infusion (p < 0.01). It decreased to 
0.2 ? 0.3 mm (p < 0.001 vs. baseline) during acetyl:holine- 
induced coronary spasm. The induced spasm resolved spon- 
taneously in eight artenes and with the administration of 
nitroglycerin in the remaining four. The diameter after 
nitroglycerin administration was 2.3 t 0.8 mm (P <: 0.001 vs. 
baseline). The lumen diameter changes in all patients after 
substance P. acetylcholine and nitroglycerin administration 
are shown in Figure IA. There was no statistical difference 
between the diameters after substance P and nitmglycenn 
administmtion. An example of the effects of substance P. 
acetylcholine and nitroplyccrin is shown in Figure 2. 
Of the I2 arteries with documented spasm, 5 were angio- 
g~,Pbically normal or nearly normal and the other 7 had 25% 
to 15% stenosis of lumen diameter at the site of spasm. The 
effect of substance P on diameter at the spasm site was 
compared between these two groups of arteries with and 
without a fixed stenotic lesion. The mean lumen diameter at 
the spasm site ia the five nom~al or nearly normal coronary 
arteries increased from 1.9 Z 0.3 mm at baseline to 2.5 ? 
0.7 mm after substance P infusion (p < 0.05); that of the 
seven stcnotic arteries increased from 1.5 2 0.5 mm at 
baseline to 1.8 + 0.6 mm after substnnce P infusion fp < 
0.01). There was no statistical difference in the change atIer 
substance P infusion between the two groups of arteries 
(t28 + 20% for the former and t30 -c 22% for the latter). 
Lumen diameter after nitroglycerin administration was 2.1 Z 
0.8 mm and 2.0 r 0.7 mm, respectively (p = NS), in these 
two groups of arteries. 
Effects on lwww dimnetrr of the wtery wirhour spnsm. 
Lumen diameter of the midportion of the artery without 
spasm was 2.0 2 0.4 mm at baseline and increased to ?.4 f 
0.6 mm after substance P infusion lp < OSNI). It then 
decreased to 1.5 t 0.5 mm after administration oface:ylcho- 
line (p < 0.001) and finally increased to 2.6 + 0.5 mm after 
nitroglycerin (P < 0.001). The diameter changes in all 
patients after administratton of these drugs are shown in 
Figure IB. There was a significant difference between the 
diameters after s”br:encc P and after nitroglycerin (p < 
0.09. 
EtTects of substance P, acetykbcdiie and nt!rc&cerb, in 
control patients. The lumen diameter of the midportion oi 
the left anterior descending ancry was 2.0 c 0.4 mm at 
basclii;; and Increased in all patients to 2.5 ? 0.4 mm after 
substance P infusion (p < 0.001). it then decreased to I.8 2 
0.4 mm after administration of acetylcholine (p < 0.05) and 
Figure 1. Changes I” coronary artery diemeter after administration 
of rubrtance P WY. acelylcholine (ACh) ad nilroglycerin (TNG) 
arc rhowun for each patient. A, Changes in diameter at the SW of 
coronary ~paam documented with acetylcholine in the II patients 
wuh coronary spaslic angina. B, Changes in diameter of the artery 
wirhout spasm in 1 I ptienls with coronary sparic anpioa. C, 
Changer in diameter of the midportion of the left anterior descend- 
ing artery in the II control patients. ‘p < 0.05: **p < 0.01: ““p < 
o.Wl: NS - nut signiticani. 
Fiiure 2. Representative example of the eiiects of substance P, 
acetylcholme and nitroglycenn on the artery with spasm iright 
coronary artery). SuMawe P caused a diffuse vssodilation i ch& 
ing the site of coronary spasm documented by acetylcholine. This 
patient, a72.year old man, had a permanent pacemaker implanted 
and two electrode cathelen are shown ,asteriskr,. 
finally increased to 2.4 + 0.4 mm after nitroglycerin (p < 
0.001). The diametsr changes in all patients after these drugs 
are shown in Figure IC. There was no statistical difference 
between the diameters after administration of substance P 
and nitroglycerin. 
Comparison of the e&et of substance P between patients 
with and without cormmry spastic angina. The percent 
changes in the lumen diameter after substance P infusion and 
ni:rwlycerin administration for the patients with coronary 
spa& angina (spasm site and nonspasm arteries) and con- 
trol patients are shown in Figure 3. After substance P 
infusion, the lumen diameter changed from baseline by +29 
f 20%, +I9 2 12% and +27 + 14%, respectively; after 
nitroglycerin administration, it changed by +42 + 28%. +33 
? 18% and +25 r 21%. respectively. There was no statis- 
tical diiTerense in Ihe effects of substance P and nitroglycerin 
among the three groups. 
Discussion 
Possible link of impaired endothelium-dependent relax- 
ation with eoronsry spasm. A previous s:udy showed that 
in isolated atherosclerotic human coronary arteries, the 
endotbelium-dependent dilation with acetylcholine was 
abolished and that with histamine and substance P was 
partially impaired (9). Recently. it has been shown (25) that 
in atherosclerotic porcine eorcmary arteries, endothelium 
dependent relaxation by way of pertussis toxin-sensitive G 
! 
Rguro 3. Percent diameter changes after administration of sub- 
stance P and nitroglycerin are shown for the arteries with and 
without spasm in the patients with coronary spastic angina and for 
the IeR anterior descending artery in control patients. See text for 
discukn. 
protein, which occurs in response to serotonin, alpha, 
adrenergic agonist and thrombin, is impaired. whereas en- 
dothelium-dependent dilator response to bradykinin is only 
partially impaired. We have shown (13) that intracomnary 
injection of acetylcholine dilates the coronary xtery in 
young humans, whereas it constricts both the atherosclerotic 
corcnary artery and the angioglaphically normal coronary 
artery in middle-aged humans. We slso have shown (26) that 
coronary artery H, receptor stimulation with histamine 
causes significant vasodilation in the angiograpbically nor- 
mal coronary artery in middle-aged humans. These experi- 
mental and clinical observations. together with other re- 
ported data (8,10-12,21). indicate haisome of the receptor- 
mediated release of the endothelium.derived relaxine. factor 
in the atherosclerotic coronary srtery or in the a&graph- 
ically normal coronary artery of middle-aged humans is 
impaired. It has been reported (27) that vasoconstrictor 
responses to norepinephrine and serotonin are augmented in 
hypercholesterolemic and atherosclerotic monkeys. 
Coronary spastic angina usually affects middle-aged hu- 
mans in a manner simile to the other forms of angina 
pectoris. We have shown (14,15) that injection of intracom- 
nary acetylcholine induces coronary spasm in >90% of 
patients with variant angina, in&d& those with normal 
coronary arteriograms (14.15). We have also shown (16) that 
coronary artery H, receptor stimulaticm with histamine at 
the dose at which vasodilator esponse was demonstrated in 
normal humans induces coronary spasm in a significant 
minority of patients with variant angina. lntracoronary ser- 
otonin infusion was shown (28) to cause vasodilation in 
normal subjects, whereas it induced spasm in patients with 
variant angina. Acetylchobne. hwammc “nd ierotonin also 
act as vasoconstrictors. Thxeforc. at least two possible 
mechanisms are suggested for the pathogen& of coronary 
spasm: I) B hyperreactivity of rhe coronary vxcular smooth 
muscle to vasoconstrictive stimuli, such as acetylcholme sod 
histamine; and 2) an impaired sndothclium-dcpsndcnt ilao- 
dilator responre to these agents. 
Demonstration of lhe endothelium-dependent varodilator 
~spotw at the site of coronary spaam. Substance P i9 a 
potent vasodilator in aany spedes~aod its dilator effect has 
been shown to depend on the presence of the vascular 
endothelium (20). Unlike acetylchobne or histamine. sub- 
stance P does not show a constrictor effect on the coronary 
artery. The present study demonstrated that intracoro”ar; 
substance P infusion dilated the coronary artenes with and 
without spasm in the patients with coronary spastic angina. 
Substance P also dilated the coronary artery of control 
patients, a finding consistent with the result 01 the previous 
study (21). The extent ofthe dilator response to substance P 
in the arteries with and without spasm in the patients with 
coronary spastic angina WBE similar to that of the coronary 
artery in control patients. The mean age of the patients with 
coronay spastic angina was higher than that of cowol 
patients (65 vs. 56 years). Aging has been shown to wxlate 
with impairment of the endothelium-dependent dilator re- 
spanse of the coronaty artery, espkally to acetylcholine 
(13.29). Furthermore, the present study showed that the 
dilator response to substance P of the artcry with spasm was 
not a&ted by the presence of an atherosclerotic lesion. 
Thus, it is indicated that the endothelium-dependent relax- 
ation in response to substance P is preserved in the artery 
with spasm of patients with coronary spastic angina, 
whether or not this artery has an atherosclerotic lesion. It 
may be pointed out that substance P infwott results in an 
increase in coronary blood Bow, which passioly induces 
Row-dependent vasodilator response. We measured coro- 
narv sinus blood Row before and after infusion ofsubotance 
I’ it& the IeR coronary artery at the same rate as [bat used 
in this studv in IO normal rubiects and found that the Row 
increased hi I2 + 12% of the baseline value (unpublished 
observations). Thus, the role of flow-dependent dilator re- 
sponse on the et&t of substacce ? demonstrated in this 
study would appear to be minimal. 
The present results do not necessarily indicate that the 
endothelium-dependent relaxation of the spasm artery is 
always preserved; rather. the results indicate that the recep- 
tor-mediated endothelium-dependent dilator response of the 
spasm artery is agonist dependent: that in response to 
substance P is preserved, ?vhereas that through muscarinic 
receptor is impaired, even m angiographically normal a&r- 
ies. The endathelium-dependent relaxation through his& 
mine H, receptor is impaired in some of the spasm arteries 
but is preserved in the majority of the arteries without a 
significant atherosclerotic lesion (16). Thus, it is suggested 
that a general impairment of the endothelium-dependent 
relaxation does not play a primary rule in the patbogenesis. 
Rather. a hypencactivity of the vascular smooth muscle to 
con~tr~ctmg stimuli should be considered m the parhogene- 
5i?. 
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